載入...
Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen
BACKGROUND: Up to one-quarter of breast cancer patients suffer clinically significant depression in the year after diagnosis, which may respond to intervention. About half may be prescribed a psychotropic medication, such as a selective serotonin reuptake inhibitor (SSRI), while completing breast ca...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2892037/ https://ncbi.nlm.nih.gov/pubmed/20156115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02841860903575273 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|